IL-1RAP blockade reduces atherosclerosis and limits plaque inflammation. (August 2022) - Mulholland, M.; Jakobsson, G.; Ljungcrantz, I.; Grentzmann, A.; Grönberg, C.; Rattik, S.; Schiopu, A.; Björkbacka, H.; Engelbertsen, D.